Your browser doesn't support javascript.
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Shehab, Nadine; Lovegrove, Maribeth; Budnitz, Daniel S.
  • Shehab N; US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Lovegrove M; Lantana Consulting Group, Atlanta, Georgia.
  • Budnitz DS; US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.
JAMA Intern Med ; 180(10): 1384-1386, 2020 10 01.
Article in English | MEDLINE | ID: covidwho-683573
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Patterns, Physicians' / Chloroquine / Coronavirus Infections / Azithromycin / Pandemics / Pre-Exposure Prophylaxis / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Intern Med Year: 2020 Document Type: Article Affiliation country: Jamainternmed.2020.2594

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Patterns, Physicians' / Chloroquine / Coronavirus Infections / Azithromycin / Pandemics / Pre-Exposure Prophylaxis / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: JAMA Intern Med Year: 2020 Document Type: Article Affiliation country: Jamainternmed.2020.2594